Production (Stage)
Perspective Therapeutics, Inc.
CATX
$2.39
-$0.12-4.78%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -85.17M | -79.28M | -63.79M | -59.02M | -58.42M |
| Total Depreciation and Amortization | 3.38M | 3.01M | 1.57M | 1.18M | 871.00K |
| Total Amortization of Deferred Charges | 7.00K | 7.00K | 7.00K | 7.00K | 7.00K |
| Total Other Non-Cash Items | 27.74M | 26.88M | 15.77M | 14.93M | 15.80M |
| Change in Net Operating Assets | 1.02M | 31.80M | 45.74M | 28.73M | 28.40M |
| Cash from Operations | -53.72M | -18.29M | -696.00K | -14.17M | -13.34M |
| Capital Expenditure | -50.00M | -54.41M | -39.89M | -10.40M | -9.94M |
| Sale of Property, Plant, and Equipment | 335.00K | 335.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -127.54M | -164.85M | -40.53M | -40.51M | -38.24M |
| Cash from Investing | -177.20M | -218.93M | -80.42M | -50.91M | -48.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -49.00K | -48.00K | -48.00K | -53.00K | -65.00K |
| Issuance of Common Stock | 132.72M | 289.08M | 289.44M | 288.82M | 167.26M |
| Repurchase of Common Stock | -287.34M | -287.34M | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 288.06M | 288.06M | 0.00 | 0.00 | 0.00 |
| Cash from Financing | 133.03M | 289.39M | 289.39M | 288.77M | 167.19M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -97.89M | 52.16M | 208.28M | 223.69M | 105.67M |